Alopecia
22 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| ABS-201 SC Multiple Doses + Placebo SC Injection for alopecia | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| AD-303A for alopecia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Adalimumab for alopecia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Baricitinib for alopecia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Baricitinib for alopecia areata | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Botulinum toxin type a for alopecia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Deuruxolitinib for alopecia areata | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for alopecia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Mesenchymal Stem Cells for alopecia | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Minoxidil for alopecia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Placebo for alopecia areata | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo - 100 mg + Ritlecitinib 50 mg for alopecia areata | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo - 50 mg + Ritlecitinib 100 mg for alopecia areata | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo + Upadacitinib for alopecia areata | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo IV + SAD IV Dose 1 - 150mg ABS201 IV Single Dose for alopecia | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PP405 0.05% Topical Gel for alopecia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ritlecitinib 100 mg for alopecia areata | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Upadacitinib for alopecia areata | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Ustekinumab for alopecia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| VDPHL01 for alopecia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| VDPHL01 BID for alopecia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| VDPHL01 QD for alopecia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |